Navigation Links
Hospira to Present at J.P. Morgan's 27th Annual Healthcare Conference January 14
Date:12/29/2008

LAKE FOREST, Ill., Dec. 29 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that Christopher B. Begley, chairman and chief executive officer, and Thomas E. Werner, senior vice president, Finance, and chief financial officer, will make a formal presentation at J.P. Morgan's 27th Annual Healthcare Conference on Wednesday, Jan. 14, 2009, at The Westin St. Francis Hotel in San Francisco.

The presentation is scheduled to begin at 10 a.m. Pacific time on Wednesday, Jan. 14, 2009. It will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the audiocast. The slides accompanying the presentation will be available on the Hospira Web site. A replay of the webcast will be available on the Hospira Web site approximately 24 hours after the live presentation.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
2. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
3. Hospira Reports Third-Quarter 2007 Results
4. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
5. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
6. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
7. Hospira Launches Generic Irinotecan Injection
8. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
9. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
10. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
11. Hospira Acquires Sculptor

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., $4Million Alliance ProgramSupportsFutureLea...uideAvailableat www.Allia n ceS c h...Newswire/--"Mr.President,youcancountusin.Withourco...isproudtobeapartofEducatetoInnovate,"saidAdolphP.F...ispanicHealth,afterattendingaWhiteHousemeetingtoda...
(Date:11/23/2009)..., CHERRYHILL,N.J.,Nov.23/PRNewswire/--Inasurveyo...icersandChiefFinancialOfficers,72percentdonotbelie...thcaresystem. ,, Accordingtoresultsofthelatests...ll,NJaccountingfirm,theeconomytoppedthelistat85per...129responsestoits1500surveyssenttocompaniesfromall...
(Date:11/23/2009)...vember 23, 2009 -- Exposure shortly after birth to...stion and particles from diesel emissions are asso...ty children, according to a new study by researche...ntal Health (CCCEH) at Columbia University,s Mailm...t to analyze the effects of exposure to airborne m...
(Date:11/23/2009)... iCRco is proud to announce i...y KLAS and received the highest grade possible amo...nufacturer to be rated “A” in sales, s...ustomer satisfaction in software functionality. iC...ghest grade by the most prestigious research firm ...
(Date:11/23/2009)..., MIAMI,Nov.23/PRNewswire/--James.G.Schwade,M.D....bleforcancerpatientsattheCyberKnifeCenterofMiami,(...reatmentforcancerisapreciselytargetedintensedoseof...lincision.Thelengthofthetreatmentcanlastfrom30minu... ,, AsthefirstCyberKnifeTreatmentCenterintheSou...
Breaking Medicine News(10 mins):Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2Health News:Exposures to metals and diesel emissions in air linked to respiratory symptoms in children 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 3
...rove collaboration regarding the emergency managem...ifically bird flu//, a training program was conduc...lving transfer of a suspected case of bird flu fro...Services Department responded immediately to the c...
...or new treatments for many conditions as they have...lt tissue//. But the human embryo stem cell is ent...elieve the human testicle may provide a less contr...great usefulness. The researchers believe similar ...
...o noise, and do not like it much! According to a n...dings// may face an increased risk of suffering a ...d that the chances of urban middle-aged adults, li...gs. All the same, if work environment reverberated...
...control in all the schools of England in a move to...//. There are currently 2,409 nurses who work...ry but the latest announcement signals a massive e...urse working with each small group of state primar...
...r has announced that it will be creating a new 'br... that inadvertently// develops between a doctor an...mplex medical terminology by the latter. This anno...uch information as possible about their disease, b...
...ecome a health hazard today with a magnitude of ab...nternal automatic defibrillators (IAD) have now co...n electrical discharge from these apparatus have b...ese were people who were leading normal lives, wit...
Other Medicine News:Health News:Human Testicular Cells Would Help In Stem Cell Research 2Health News:Seconds Between Life And Death 2
(Date:11/23/2009)..., NOVATO,Calif.,Nov.23/PRNewswire-FirstCall/--Rapt...aq: RPTP ),todayannouncedresultsfromaPhase2bclinic...tartrate("DRCysteamine")inpatientswithnephropathic...iversityofCalifornia,SanDiego("UCSD")GeneralClinic...macokineticsandpharmacodynamicsofasingledoseofDRCy...
(Date:11/23/2009)..., EMERYVILLE,Calif.,Nov.23/PRNewswire-FirstCall/--...TI")announcedtodaythatitsboardofdirectorshasdeclar...ock,whichwillbepaidonDecember9,2009tostockholderso...rdinarydividendfollowsstockholderapprovalofthediss...ddissolutionandanearlierextraordinarydividendof$0....
(Date:11/20/2009)..., WAYNE, Pa., Nov. 20 ...nced the results for its fiscal first quarter ende...r of fiscal 2010, product revenue decreased approx...e three-month period ended September 30, 2009 as c...Company reported the decreased net revenue of $8,4...
Breaking Medicine Technology:Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Number of Underweight Kids in U S Continues to Shrink 51798 1AHIMA Launches New Interactive myPHR com Web Site 51796 1AHIMA Launches New Interactive myPHR com Web Site 51796 2AHIMA Launches New Interactive myPHR com Web Site 51796 3Netsmart Technologies Acquires Pharmacy Management Software Company 51795 1Netsmart Technologies Acquires Pharmacy Management Software Company 51795 2Netsmart Technologies Acquires Pharmacy Management Software Company 51795 3
...titis, the common, chronic, inflammatory skin dise...ng in prevalence over the past two decades and aff...ing to current estimates, approximately 15 percent...d other industrialized countries around the world ...f life. By comparison, only an estimated 3 percent...
...ition- , , -Biologics License Application for Wri...iled Within Two Weeks- , , , EXTON, Pa., March 5...y positive top-line efficacy results from a Phase ...agen Therapy(TM) for the treatment of moderate to ...acy endpoints and was statistically significant, m...
Other Medicine Technology:Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children 2Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children 3Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children 4Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children 5Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 2Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 3Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 4Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 5Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 6
...r provides effective therapy at an affordable pric...home or on the go and features ease of use, a 5-ye...ave come to count on from DeVilbiss., ,The PulmoA... those patients seeking a quality, effective treat...
...th low to moderate pain in one or more limbs assoc...d back. This may include people with post laminect...isc surgery or degenerative disc disease and Compl...s+ was designed to give patients more control over...
TurboFlow™ System 3000 Insufflator, 10 liter
KLEPPINGER tongs
Medicine Products: